albendazole has been researched along with Filariasis in 52 studies
Filariasis: Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Repeated, single, oral doses of combinations of ivermectin, diethylcarbamazine (DEC) or albendazole are recognized as important tools for parasite control in lymphatic filariasis." | 9.09 | Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. ( Babu, BS; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK, 2000) |
| "Egypt was one of the first countries to implement a national programme to eliminate lymphatic filariasis based on WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine and albendazole (target population, 2." | 7.73 | Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. ( Abd Elaziz, KM; Ahmed, ES; El Setouhy, M; Farid, HA; Helmy, H; Ramzy, RM; Shannon, WD; Weil, GJ, 2006) |
| "punctulatus vector." | 5.35 | The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. ( Bockarie, MJ; Kastens, W; Kazura, JW; King, CL; Laney, SJ; Susapu, M; Weil, GJ; Williams, SA, 2008) |
| "In Africa, albendazole and ivermectin are currently used in combination for annual mass drug administration (MDA) for lymphatic filariasis (LF) elimination." | 5.20 | Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi. ( Banda, LG; French, N; Horton, J; Koole, O; Ngwira, BM; Phiri, AJ; Piston, WN; Taegtmeyer, M; Tafatatha, TT; Wilson, TP, 2015) |
| "Repeated, single, oral doses of combinations of ivermectin, diethylcarbamazine (DEC) or albendazole are recognized as important tools for parasite control in lymphatic filariasis." | 5.09 | Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. ( Babu, BS; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK, 2000) |
| "In India, annual rounds of mass drug administration (MDA) based on diethylcarbamazine and albendazole are used to control filariasis, which is a major public-health problem." | 3.75 | Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala. ( Aswathy, S; Beteena, K; Leelamoni, K, 2009) |
| "Currently, annual mass treatments with albendazole (ABZ) plus ivermectin (IVM) or diethylcarbamazine (DEC) are administered under the Global Programme to Eliminate Lymphatic Filariasis (GPELF)." | 3.74 | An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. ( Basáñez, MG; Churcher, TS; Prichard, RK; Schwab, AE; Schwab, AJ, 2007) |
| "The Global Program to Eliminate Lymphatic Filariasis has been implemented to reduce human microfilaremia to levels low enough to break the transmission of the disease by using single annual doses of albendazole in combination with diethylcarbamazine or ivermectin." | 3.73 | Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. ( Boakye, DA; Kyelem, D; Prichard, RK; Schwab, AE, 2005) |
| "Egypt was one of the first countries to implement a national programme to eliminate lymphatic filariasis based on WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine and albendazole (target population, 2." | 3.73 | Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. ( Abd Elaziz, KM; Ahmed, ES; El Setouhy, M; Farid, HA; Helmy, H; Ramzy, RM; Shannon, WD; Weil, GJ, 2006) |
| "The Global Program for the Elimination of Lymphatic Filariasis (GPELF) intends to achieve its aims through yearly mass treatments with albendazole (ABZ) combined with ivermectin (IVM) or diethylcarbamazine (DEC)." | 3.73 | Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti. ( Basáñez, MG; Churcher, TS; Prichard, RK; Schwab, AE; Schwab, AJ, 2006) |
| "Albendazole, anthelmintic benzimidazole (BZ) is being co-administered with an antifilarial drug, diethylcarbamazine (DEC), in lymphatic filariasis (LF) elimination programmes." | 3.72 | Detection of codon for amino acid 200 in isotype 1 beta-tubulin gene of Wuchereria bancrofti isolates, implicated in resistance to benzimidazoles in other nematodes. ( Das, PK; Hoti, SL; Subramaniyan, K, 2003) |
| "These findings suggest that increasing the dosage and frequency of albendazole-ivermectin treatment enhances suppression of microfilariae but that this effect may not be attributable to improved adulticidal activity." | 2.75 | Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. ( Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Dembele, B; Diallo, AA; Diaman Keita, A; Dolo, H; Doumbia, SS; Fay, MP; Klion, AD; Konate, S; Nutman, TB; Sanogo, D; Soumaoro, L; Traore, SF, 2010) |
| "A six-week regimen of doxycycline treatment against filariasis showed amelioration of pathologic conditions of hydrocele patients with active infection." | 2.74 | Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. ( Adjei, O; Batsa, L; Debrah, AY; Hoerauf, A; Lawson, B; Mand, S; Marfo-Debrekyei, Y; Pfarr, K; Taylor, M, 2009) |
| " These data showed no statistically significant difference in the efficacy of the two drug regimens in lowering the microfilaria reservoir, but they support the use of diethylcarbamazine combined with albendazole in mass treatment programs on the basis of greater activity against adult worms." | 2.73 | Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. ( Alpers, MP; Bockarie, MJ; Hazlett, F; Ibam, I; Kastens, W; Kazura, JW; Tavul, L; Tisch, DJ, 2007) |
| " A randomized double-blind field trial with a single dose of ivermectin (150-200 microg/kg body weight) alone or in combination with albendazole (400 mg) was subsequently carried out among these children." | 2.71 | The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. ( Dunyo, SK; Magesa, SM; Malecela-Lazaro, MN; Michael, E; Simonsen, PE, 2004) |
| "Albendazole and DEC/ALB were equally efficacious in treating intestinal helminths and for children with W." | 2.71 | Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. ( Beach, MJ; Brissau, JM; Desire, D; Fox, LM; Furness, BW; Haser, JK; Lafontant, J; Lammie, PJ; Milord, MD, 2005) |
| "Filariasis is a global health problem targeted for elimination." | 1.48 | Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models. ( Archer, J; Gamble, J; Marriott, AE; Murphy, E; Sjoberg, H; Steven, A; Taylor, MJ; Turner, JD; Tyrer, H, 2018) |
| "punctulatus vector." | 1.35 | The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. ( Bockarie, MJ; Kastens, W; Kazura, JW; King, CL; Laney, SJ; Susapu, M; Weil, GJ; Williams, SA, 2008) |
| "Diethylcarbamazine (DEC) has been used for decades in control programs as an effective microfilaricide, although its efficacy in killing adult worms is only around 50% and its direct mode of action is unclear." | 1.34 | Comparative analysis of a chemotherapy effect on the cuticular surface of Wuchereria bancrofti adult worms in vivo. ( Dreyer, G; Lanfredi, RM; Lins, R; Norões, J; Oliveira-Menezes, A, 2007) |
| "A dog infested with Filaroides osleri was dosed with albendazole at 9,5 mg/kg every day for 55 days." | 1.26 | The treatment of Filaroides osleri infestation with albendazole. ( Petrick, SW; van Heerden, J, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.85) | 18.7374 |
| 1990's | 4 (7.69) | 18.2507 |
| 2000's | 29 (55.77) | 29.6817 |
| 2010's | 17 (32.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeleke, AA | 1 |
| Faraj, J | 1 |
| Mander, J | 1 |
| Burnett, JR | 1 |
| Prentice, D | 1 |
| Turner, JD | 3 |
| Sharma, R | 1 |
| Al Jayoussi, G | 1 |
| Tyrer, HE | 1 |
| Gamble, J | 2 |
| Hayward, L | 1 |
| Priestley, RS | 1 |
| Murphy, EA | 1 |
| Davies, J | 1 |
| Waterhouse, D | 1 |
| Cook, DAN | 1 |
| Clare, RH | 1 |
| Cassidy, A | 1 |
| Steven, A | 2 |
| Johnston, KL | 1 |
| McCall, J | 1 |
| Ford, L | 1 |
| Hemingway, J | 1 |
| Ward, SA | 1 |
| Taylor, MJ | 3 |
| Marriott, AE | 1 |
| Sjoberg, H | 1 |
| Tyrer, H | 1 |
| Murphy, E | 1 |
| Archer, J | 1 |
| Choi, TW | 1 |
| Cho, JH | 1 |
| Ahnn, J | 1 |
| Song, HO | 1 |
| Supali, T | 1 |
| Djuardi, Y | 1 |
| Bradley, M | 1 |
| Noordin, R | 1 |
| Rückert, P | 1 |
| Fischer, PU | 1 |
| Talaat, KR | 1 |
| Babu, S | 1 |
| Menon, P | 1 |
| Kumarasamy, N | 1 |
| Sharma, J | 1 |
| Arumugam, J | 1 |
| Dhakshinamurthy, K | 1 |
| Srinivasan, R | 1 |
| Poongulali, S | 1 |
| Gu, W | 1 |
| Fay, MP | 2 |
| Swaminathan, S | 1 |
| Nutman, TB | 3 |
| Pan, C | 1 |
| Cai, B | 1 |
| Wang, L | 1 |
| Tafatatha, TT | 1 |
| Ngwira, BM | 1 |
| Taegtmeyer, M | 1 |
| Phiri, AJ | 1 |
| Wilson, TP | 1 |
| Banda, LG | 1 |
| Piston, WN | 1 |
| Koole, O | 1 |
| Horton, J | 1 |
| French, N | 1 |
| Bal, M | 1 |
| Sahu, PK | 1 |
| Mandal, N | 1 |
| Satapathy, AK | 1 |
| Ranjit, M | 1 |
| Kar, SK | 1 |
| De Britto, RL | 1 |
| Vanamail, P | 1 |
| Sankari, T | 1 |
| Vijayalakshmi, G | 1 |
| Das, LK | 1 |
| Pani, SP | 1 |
| Liang, JL | 1 |
| King, JD | 1 |
| Ichimori, K | 1 |
| Handzel, T | 1 |
| Pa'au, M | 1 |
| Lammie, PJ | 3 |
| Weil, GJ | 4 |
| Kastens, W | 2 |
| Susapu, M | 1 |
| Laney, SJ | 1 |
| Williams, SA | 1 |
| King, CL | 1 |
| Kazura, JW | 3 |
| Bockarie, MJ | 2 |
| Debrah, AY | 2 |
| Mand, S | 2 |
| Marfo-Debrekyei, Y | 1 |
| Batsa, L | 1 |
| Pfarr, K | 2 |
| Lawson, B | 1 |
| Taylor, M | 1 |
| Adjei, O | 2 |
| Hoerauf, A | 2 |
| El-Shazly, AM | 1 |
| Saker, TI | 1 |
| El-Fayoumy, KN | 1 |
| Aboulmagd, AA | 1 |
| El-Ghareeb, AS | 1 |
| Zalouk, TK | 1 |
| Abdel-Tawab, AH | 1 |
| Aswathy, S | 1 |
| Beteena, K | 1 |
| Leelamoni, K | 1 |
| Cárdenas, MQ | 1 |
| Oliveira-Menezes, A | 2 |
| Lanfredi, RM | 2 |
| Dembele, B | 1 |
| Coulibaly, YI | 2 |
| Dolo, H | 1 |
| Konate, S | 1 |
| Coulibaly, SY | 1 |
| Sanogo, D | 1 |
| Soumaoro, L | 1 |
| Coulibaly, ME | 1 |
| Doumbia, SS | 1 |
| Diallo, AA | 1 |
| Traore, SF | 2 |
| Diaman Keita, A | 1 |
| Klion, AD | 2 |
| Tomlow, B | 1 |
| Rellum, M | 1 |
| Itoh, M | 1 |
| Weerasooriya, MV | 1 |
| Yahathugoda, TC | 1 |
| Takagi, H | 1 |
| Samarawickrema, WA | 1 |
| Nagaoka, F | 1 |
| Kimura, E | 1 |
| Serbus, LR | 1 |
| Landmann, F | 1 |
| Bray, WM | 1 |
| White, PM | 1 |
| Ruybal, J | 1 |
| Lokey, RS | 1 |
| Debec, A | 1 |
| Sullivan, W | 1 |
| Rajendran, R | 1 |
| Sunish, IP | 1 |
| Mani, TR | 1 |
| Munirathinam, A | 1 |
| Abdullah, SM | 1 |
| Augustin, DJ | 1 |
| Satyanarayana, K | 1 |
| Abdul-Fattah, MM | 1 |
| El-Karamany, EM | 1 |
| El-Gindy, AM | 1 |
| Nimr, WA | 1 |
| El-Shamy, MH | 1 |
| De Silva, NR | 1 |
| Pathmeswaran, A | 1 |
| Fernando, SD | 1 |
| Weerasinghe, CR | 1 |
| Selvaratnam, RR | 1 |
| Padmasiri, EA | 1 |
| Montresor, A | 1 |
| Hoti, SL | 1 |
| Subramaniyan, K | 1 |
| Das, PK | 1 |
| Keiser, PB | 1 |
| Keita, F | 1 |
| Traore, D | 1 |
| Diallo, A | 1 |
| Diallo, DA | 1 |
| Semnani, RT | 1 |
| Doumbo, OK | 1 |
| Simonsen, PE | 1 |
| Magesa, SM | 1 |
| Dunyo, SK | 1 |
| Malecela-Lazaro, MN | 1 |
| Michael, E | 1 |
| Tippawangkosol, P | 1 |
| Choochote, W | 1 |
| Na-Bangchang, K | 1 |
| Jitpakdi, A | 1 |
| Pitasawat, B | 1 |
| Riyong, D | 1 |
| Sharma, DC | 1 |
| Khan, MA | 1 |
| Gaur, RL | 2 |
| Dixit, S | 2 |
| Saleemuddin, M | 1 |
| Murthy, PK | 2 |
| Farid, HA | 3 |
| Kamal, SA | 1 |
| Adham, FK | 1 |
| Ramzy, RM | 3 |
| Hammad, RE | 1 |
| Hassan, MM | 1 |
| El Setouhy, M | 2 |
| Fox, LM | 1 |
| Furness, BW | 1 |
| Haser, JK | 1 |
| Desire, D | 1 |
| Brissau, JM | 1 |
| Milord, MD | 1 |
| Lafontant, J | 1 |
| Beach, MJ | 2 |
| Schwab, AE | 3 |
| Boakye, DA | 1 |
| Kyelem, D | 1 |
| Prichard, RK | 3 |
| Helmy, H | 1 |
| Ahmed, ES | 1 |
| Abd Elaziz, KM | 1 |
| Shannon, WD | 1 |
| Muehlfeld, J | 1 |
| McGarry, HF | 1 |
| Churcher, TS | 2 |
| Schwab, AJ | 2 |
| Basáñez, MG | 2 |
| Dreyer, G | 2 |
| Addiss, D | 1 |
| Williamson, J | 1 |
| Norões, J | 2 |
| Yongyuth, P | 1 |
| Koyadun, S | 1 |
| Jaturabundit, N | 1 |
| Sampuch, A | 1 |
| Bhumiratana, A | 1 |
| Sahoo, MK | 1 |
| Khanna, M | 1 |
| Singh, S | 1 |
| Tavul, L | 1 |
| Ibam, I | 1 |
| Hazlett, F | 1 |
| Tisch, DJ | 1 |
| Alpers, MP | 1 |
| Lins, R | 1 |
| Denham, DA | 1 |
| Liron, DA | 1 |
| Brandt, E | 1 |
| van Heerden, J | 1 |
| Petrick, SW | 1 |
| Duarte, Z | 2 |
| Gantier, JC | 2 |
| Gayral, P | 2 |
| Addiss, DG | 1 |
| Streit, TG | 1 |
| Lutwick, S | 1 |
| LeConte, FH | 1 |
| Lafontant, JG | 1 |
| Hightower, AW | 1 |
| Sharp, D | 1 |
| Maher, D | 1 |
| Ottesen, EA | 1 |
| Shenoy, RK | 1 |
| John, A | 1 |
| Babu, BS | 1 |
| Suma, TK | 1 |
| Kumaraswami, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection[NCT00344279] | 1,000 participants (Anticipated) | Observational | 2005-08-08 | Completed | |||
| Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi, Open Label Study[NCT01213576] | 70 participants (Actual) | Interventional | 2009-01-31 | Terminated (stopped due to Introduction of National Mass Drug Administration Campaign and failure to identify appropriate participants.) | |||
| Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection: Double Blind Randomised Clinical Trial (RCT) to Study the Efficacy of Different Co-administration and Sequential Administration[NCT02005653] | Phase 4 | 146 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in Subjects With Schistosomiasis: A Pilot Study[NCT02734186] | Phase 4 | 0 participants (Actual) | Interventional | 2016-04-06 | Withdrawn | ||
| Alternative Chemotherapies for Lymphatic Filariasis (LF) Treatment and Elimination in Africa [Cote d'Ivoire][NCT02974049] | 189 participants (Actual) | Interventional | 2015-01-31 | Completed | |||
| Effect of Albendazole and Ivermectin Dose on Wuchereria Bancrofti Microfilarial Clearance in Mali: A Randomized, Open Label Study[NCT00339417] | Phase 2 | 1,000 participants (Anticipated) | Interventional | 2006-02-22 | Completed | ||
| Treatment of Mansonella Perstans Infection in an Area Coendemic for Lymphatic Filariasis: A Pilot Study of the Effects of Doxycycline[NCT00340691] | Phase 2 | 1,500 participants | Interventional | 2004-12-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Microfilaria clearance will be assessed in regard to dosage as well as frequency of treatment. Microfilarial clearance is defined by non-detection of microfilaria in the night blood sample. (NCT01213576)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| Albendazole 400mg and Ivermectin 200mcg/kg Annually | 15 |
| Albendazole 800mg and Ivermectin 400mcg/kg Annually | 14 |
| Albendazole 400mg and Ivermectin 200mcg/kg Biannually | 13 |
| Albendazole 800mg and Ivermectin 400mcg /kg Bi-annually | 17 |
Microfilaria will be detected using the nucleopore filtration technique and analysed according to the respective treatment arms at the 24 month time point. Microfilarial clearance will be defined by non-detection of microfilaria in the night blood sample (NCT01213576)
Timeframe: 24 months
| Intervention | participants (Number) |
|---|---|
| Albendazole 400mg and Ivermectin 200mcg/kg Annually | 17 |
| Albendazole 800mg and Ivermectin 400mcg/kg Annually | 17 |
| Albendazole 400mg and Ivermectin 200mcg/kg Biannually | 14 |
| Albendazole 800mg and Ivermectin 400mcg /kg Bi-annually | 17 |
14 trials available for albendazole and Filariasis
| Article | Year |
|---|---|
Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi.
Topics: Adult; Albendazole; Animals; Drug Therapy, Combination; Endemic Diseases; Female; Filariasis; Follow | 2015 |
Enhanced efficacy of sequential administration of Albendazole for the clearance of Wuchereria bancrofti infection: Double blind RCT.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Double-Blind Method; Doxycycline; Drug Therapy, Com | 2015 |
Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline.
Topics: Adolescent; Adult; Albendazole; Animals; Anti-Bacterial Agents; Double-Blind Method; Doxycycline; Fi | 2009 |
The kinetics of microfilaraemia and antigenaemia status among asymptomatic bancroftian filariasis before and after treatment.
Topics: Albendazole; Antigens, Helminth; Drug Therapy, Combination; Egypt; Filariasis; Filaricides; Humans; | 2009 |
Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Drug Therapy, Combination; Endemic Diseases; Female; | 2010 |
The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.
Topics: Adolescent; Albendazole; Analysis of Variance; Animals; Child; Double-Blind Method; Drug Therapy, Co | 2004 |
Effects of combined diethylcarbamazine and albendazole treatment of bancroftian filariasis on parasite uptake and development in Culex pipiens L.
Topics: Adult; Albendazole; Animals; Anthelmintics; Carrier State; Culex; Diethylcarbamazine; Drug Therapy, | 2005 |
Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children.
Topics: Albendazole; Animals; Anthelmintics; Child; Diethylcarbamazine; Double-Blind Method; Drug Therapy, C | 2005 |
A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Double-Blind Method; Doxycycline; Drug | 2006 |
Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Diethylcarbamazine; Drug Combinations; Filariasis; Fi | 2006 |
Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
Topics: Adult; Albendazole; Analysis of Variance; Animals; Antigens, Helminth; Diethylcarbamazine; Filariasi | 2006 |
Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Female; Filariasis; Humans; Male; Wuchereria bancro | 2007 |
Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Topics: Albendazole; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Filariasis; Filari | 1997 |
Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Topics: Albendazole; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Filariasis; Filari | 1997 |
Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Topics: Albendazole; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Filariasis; Filari | 1997 |
Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Topics: Albendazole; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Filariasis; Filari | 1997 |
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Drug Administratio | 2000 |
38 other studies available for albendazole and Filariasis
| Article | Year |
|---|---|
Parasitic chyluria in a 72-year-old Sierra Leonean woman: A case report.
Topics: Aged; Albendazole; Anthelmintics; Chyle; Female; Filariasis; Humans; Ivermectin; Kidney Diseases; Tr | 2019 |
Filiarial chyluria with nephrotic-range proteinuria and associated hypoalbuminaemia and hypogammaglobulinaemia secondary to bilateral lymphorenal fistulae.
Topics: Agammaglobulinemia; Albendazole; Chyle; Combined Modality Therapy; Diagnosis, Differential; Filarias | 2017 |
Albendazole and antibiotics synergize to deliver short-course anti-
Topics: Albendazole; Animals; Anti-Bacterial Agents; Benzimidazoles; Brugia malayi; Drug Synergism; Female; | 2017 |
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.
Topics: Albendazole; Animals; Brugia malayi; Drug Evaluation, Preclinical; Filariasis; Filaricides; Mice; Mi | 2018 |
Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery.
Topics: Albendazole; Amino Acid Sequence; Animals; Antinematodal Agents; Caenorhabditis elegans; Caenorhabdi | 2018 |
Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Antibodies, Helmint | 2013 |
Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.
Topics: Adult; Albendazole; Animals; Case-Control Studies; CD4 Lymphocyte Count; Coinfection; Diethylcarbama | 2015 |
Multiple frailty model for clustered interval-censored data with frailty selection.
Topics: Albendazole; Animals; Diethylcarbamazine; Filariasis; Humans; Likelihood Functions; Proportional Haz | 2017 |
Maternal Infection Is a Risk Factor for Early Childhood Infection in Filariasis.
Topics: Adult; Aging; Albendazole; Antigens, Helminth; Cohort Studies; Diethylcarbamazine; Female; Filariasi | 2015 |
Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.
Topics: Adolescent; Adult; Albendazole; American Samoa; Animals; Anthelmintics; Antigens, Helminth; Child; C | 2008 |
The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
Topics: Adult; Aging; Albendazole; Animals; Anopheles; Anthelmintics; Antigens, Helminth; Child; Culicidae; | 2008 |
Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Analysis of Variance; Diethylcarbamazine; D | 2009 |
Effects of albendazole on Litomosoides chagasfilhoi (Nematoda: Filarioidea) females in vivo.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Blood; Cytoplasm; Disease Models, Animal; | 2010 |
Higher-dose, more frequent treatment of Wuchereria bancrofti.
Topics: Albendazole; Animals; Drug Therapy, Combination; Filariasis; Filaricides; Humans; Ivermectin; Parasi | 2010 |
[A woman with painful, swollen legs].
Topics: Aged; Albendazole; Female; Filariasis; Filaricides; Humans; Leg; Treatment Outcome | 2011 |
Effects of 5 rounds of mass drug administration with diethylcarbamazine and albendazole on filaria-specific IgG4 titers in urine: 6-year follow-up study in Sri Lanka.
Topics: Adolescent; Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine; D | 2011 |
A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.
Topics: Albendazole; Animals; Brugia malayi; Cell Line; Drosophila melanogaster; Filariasis; Microbial Sensi | 2012 |
The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Topics: Adolescent; Adult; Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Cross-Sectiona | 2002 |
Bancroftian filariasis: clinical parasitologic and serologic evaluation after 4 years applying two antifilarial regimens.
Topics: Adolescent; Adult; Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Diethylcarbama | 2002 |
Impact of mass chemotherapy for the control of filariasis on geohelminth infections in Sri Lanka.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Child; Diethylcarbamazine; Dr | 2003 |
Detection of codon for amino acid 200 in isotype 1 beta-tubulin gene of Wuchereria bancrofti isolates, implicated in resistance to benzimidazoles in other nematodes.
Topics: Albendazole; Amino Acid Sequence; Animals; Anthelmintics; Base Sequence; Drug Resistance; Filariasis | 2003 |
Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Albendazole; Animals; Drug Adminis | 2003 |
The in vitro effect of albendazole, ivermectin, diethylcarbamazine, and their combinations against infective third-stage larvae of nocturnally subperiodic Brugia malayi (Narathiwat strain): scanning electron microscopy.
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Brugia malayi; Circadian Rhythm; Diethylc | 2004 |
India expands mass chemotherapy to eradicate filariasis.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Filariasis; Filaricides; Filari | 2004 |
Responses of Mastomys coucha, that have been infected with Brugia malayi and treated with diethylcarbamazine or albendazole, to re-exposure to infection.
Topics: Albendazole; Animals; Brugia malayi; Cell Division; Diethylcarbamazine; Filariasis; Filaricides; Imm | 2004 |
Filariasis elimination in Egypt: impact of low microfilaraemics as sources of infection for mosquitoes.
Topics: Adolescent; Adult; Albendazole; Animals; Carrier State; Culex; Diethylcarbamazine; Disease Reservoir | 2003 |
Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment.
Topics: Albendazole; Animals; Benzimidazoles; Burkina Faso; Drug Resistance; Drug Therapy, Combination; Fila | 2005 |
Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
Topics: Albendazole; Animals; Child; Child, Preschool; Cross-Sectional Studies; Culex; Diethylcarbamazine; E | 2006 |
Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.
Topics: Albendazole; Alleles; Animals; Anthelmintics; Antiparasitic Agents; Culicidae; Diethylcarbamazine; D | 2006 |
Anti-filarial activity of novel formulations of albendazole against experimental brugian filariasis.
Topics: Albendazole; Animals; Brugia malayi; Dosage Forms; Filariasis; Filaricides; Gerbillinae; Murinae; Ti | 2007 |
An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy.
Topics: Age Factors; Albendazole; Animals; Antiparasitic Agents; Computer Simulation; Drug Resistance, Multi | 2007 |
Comparative analysis of a chemotherapy effect on the cuticular surface of Wuchereria bancrofti adult worms in vivo.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Filariasis; Filaricides; | 2007 |
The anthelmintic effects of albendazole on Brugia pahangi.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Brugia; Cats; Female; Filariasis; Filarioidea; | 1980 |
The treatment of Filaroides osleri infestation with albendazole.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Cat Diseases; Cats; Dogs; Filariasis; Male | 1980 |
Macrofilaricidal activity of albendazole-ivermectin combination: histopathological evaluation of adult Molinema dessetae.
Topics: Albendazole; Animals; Drug Therapy, Combination; Filariasis; Filaricides; Filarioidea; Ivermectin; M | 1994 |
Activity of albendazole-ivermectin combination and other filaricidal drugs against infective larvae, preadult, microfilariae and adult worms of Molinema dessetae in the rodent Proechimys oris.
Topics: Administration, Oral; Albendazole; Animals; Diethylcarbamazine; Drug Combinations; Female; Filariasi | 1994 |
Another tropical-drug donation.
Topics: Albendazole; Animals; Anthelmintics; Drug Industry; Filariasis; Humans; Wuchereria bancrofti | 1998 |
The Global Lymphatic Filariasis Initiative.
Topics: Albendazole; Anthelmintics; Filariasis; Humans; International Cooperation | 2000 |